Loading clinical trials...
Loading clinical trials...
This registry aims to monitor the safety of Qizhi Tongluo Capsules and to identify the potential risk factors for its adverse drug reactions.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zhong Wang
Collaborators
NCT07216846 · Fall, Fall Accident, and more
NCT06723860 · Post Intensive Care Syndrome (PICS), Polypharmacy, and more
NCT04692220 · Adverse Drug Events
NCT02482025 · Drug-Related Side Effects and Adverse Reactions, Adverse Drug Events
NCT04547335 · Adverse Drug Reactions
Ningming County Hospital of Chinese Medicine
Changzuo, Guangxi
Fangchenggang City Hospital of Chinese Medicine
Fangchenggang, Guangxi
The First Affiliated Hospital of Guangxi University of Chinese Medicine
Nanning, Guangxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions